McCarthy Sean A. — SEC insider filings

SEC reporting owner CIK 1654058. 32 insider filings on record with FilingPulse; latest filed 2026-10-16.

Transaction summary — filings shown

Covers all 32 filings on record, filed 2020-09-23 to 2026-10-16. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
CytomX Therapeutics, Inc. (CTMX)CEO, Director32—13 legs · 700,027 sh · $3,445,26154

Insider filings — McCarthy Sean A.

FiledFormIssuerReported transactionsSource
2026-10-164/ACytomX Therapeutics, Inc. (CTMX)Option exercise (M): 101,793 @ $1.59 · Sale (S): 101,793 @ $4.54 · Option exercise (M): 101,793 (derivative) @ $0EDGAR
2026-03-194CytomX Therapeutics, Inc. (CTMX)Sale (S): 118,969 @ $6.42EDGAR
2026-02-044CytomX Therapeutics, Inc. (CTMX)Grant/award (A): 210,000 @ $0 · Grant/award (A): 980,000 (derivative) @ $0EDGAR
2025-11-104CytomX Therapeutics, Inc. (CTMX)Sale (S): 101,793 @ $4.54EDGAR
2025-09-304CytomX Therapeutics, Inc. (CTMX)Grant/award (A): 570,000 (derivative) @ $0 · Grant/award (A): 285,000 (derivative) @ $0EDGAR
2025-06-174CytomX Therapeutics, Inc. (CTMX)Option exercise (M): 150,000 @ $0 · Sale (S): 55,511 @ $2.69 · Option exercise (M): 150,000 (derivative) @ $0EDGAR
2025-03-204CytomX Therapeutics, Inc. (CTMX)Sale (S): 37,656 @ $0.60EDGAR
2025-02-064CytomX Therapeutics, Inc. (CTMX)Grant/award (A): 180,000 @ $0 · Grant/award (A): 195,000 @ $0 · Grant/award (A): 800,000 (derivative) @ $0 · Grant/award (A): 390,000 (derivative) @ $0EDGAR
2024-08-224CytomX Therapeutics, Inc. (CTMX)Option exercise (M): 37,500 @ $0 · Sale (S): 13,898 @ $1.23 · Option exercise (M): 37,500 (derivative) @ $0EDGAR
2024-03-284CytomX Therapeutics, Inc. (CTMX)Option exercise (M): 109,768 @ $1.57 · Option exercise (M): 109,768 (derivative) @ $0EDGAR
2024-03-214CytomX Therapeutics, Inc. (CTMX)Sale (S): 20,223 @ $2.09EDGAR
2024-01-194CytomX Therapeutics, Inc. (CTMX)Grant/award (A): 90,000 @ $0 · Grant/award (A): 420,000 (derivative) @ $0 · Grant/award (A): 260,000 (derivative) @ $0EDGAR
2023-12-224CytomX Therapeutics, Inc. (CTMX)Sale (S): 13,551 @ $1.38EDGAR
2023-12-194CytomX Therapeutics, Inc. (CTMX)Option exercise (M): 37,500 @ $0 · Option exercise (M): 37,500 (derivative) @ $0EDGAR
2023-09-224CytomX Therapeutics, Inc. (CTMX)Grant/award (A): 40,000 @ $0 · Sale (S): 14,601 @ $1.30EDGAR
2023-05-234CytomX Therapeutics, Inc. (CTMX)Option exercise (M): 16,535 @ $1.57 · Option exercise (M): 16,535 (derivative) @ $0EDGAR
2023-03-204CytomX Therapeutics, Inc. (CTMX)Sale (S): 7,121 @ $1.88EDGAR
2023-02-064CytomX Therapeutics, Inc. (CTMX)Grant/award (A): 105,000 @ $0 · Grant/award (A): 315,000 (derivative) @ $0 · Grant/award (A): 300,000 (derivative) @ $0EDGAR
2022-08-124CytomX Therapeutics, Inc. (CTMX)Grant/award (A): 450,000 (derivative) @ $0 · Grant/award (A): 75,000 (derivative) @ $0EDGAR
2022-07-214CytomX Therapeutics, Inc. (CTMX)Grant/award (A): 40,000 @ $0 · Sale (S): 14,911 @ $1.42EDGAR
2022-05-114CytomX Therapeutics, Inc. (CTMX)Option exercise (M): 66,742 @ $0.94 · Option exercise (M): 24,189 @ $0.94 · Option exercise (M): 66,742 (derivative) @ $0 · Option exercise (M): 24,189 (derivative) @ $0EDGAR
2022-02-044CytomX Therapeutics, Inc. (CTMX)Grant/award (A): 75,000 @ $0 · Grant/award (A): 450,000 (derivative) @ $0EDGAR
2021-10-264CytomX Therapeutics, Inc. (CTMX)Grant/award (A): 100,000 (derivative) @ $0 · Grant/award (A): 80,000 (derivative) @ $0EDGAR
2021-08-134CytomX Therapeutics, Inc. (CTMX)Option exercise (M): 92,113 @ $1.13 · Option exercise (M): 92,113 (derivative) @ $0EDGAR
2021-06-214CytomX Therapeutics, Inc. (CTMX)Sale (S): 100,000 @ $7.04EDGAR
2021-06-164CytomX Therapeutics, Inc. (CTMX)Option exercise (M): 30 @ $1.13 · Option exercise (M): 10 @ $0.94 · Option exercise (M): 30 (derivative) @ $0 · Option exercise (M): 10 (derivative) @ $0EDGAR
2021-06-084CytomX Therapeutics, Inc. (CTMX)Gift (G): 4,500 @ $0EDGAR
2021-04-024CytomX Therapeutics, Inc. (CTMX)Option exercise (M): 100,000 @ $1.13 · Sale (S): 100,000 @ $7.49 · Option exercise (M): 100,000 (derivative) @ $0EDGAR
2021-03-024CytomX Therapeutics, Inc. (CTMX)Grant/award (A): 400,000 (derivative) @ $0 · Grant/award (A): 200,000 (derivative) @ $0EDGAR
2020-12-284CytomX Therapeutics, Inc. (CTMX)Option exercise (M): 100,000 @ $1.13 · Option exercise (M): 100,000 (derivative) @ $0EDGAR
2020-12-074CytomX Therapeutics, Inc. (CTMX)Grant/award (A): 930 @ $6.39EDGAR
2020-09-234CytomX Therapeutics, Inc. (CTMX)Option exercise (M): 20,500 @ $6.61 · Option exercise (M): 20,500 (derivative) @ $0EDGAR

FilingPulse's Form 4 archive currently extends back to 2020-09-21 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1654058 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs